BioTrinity Testimonials 2008


All testimonials are reproduced with kind permission from their authors, and were comments received in the days and weeks following the conference.

 

"As a direct result of our focused partnering meetings we introduced proteros to potential clients at BioTrinity 2008 which we are pleased to report resulted in several new opportunities and one of which has developed into a substantial business relationship" Gordon J Woodrow, VP Business Development, Proteros biostructures GmbH, October 2008 following BioTrinity 2008.


"thank you for once again organising an excellent BioTrinity conference ... so much activity and interaction between all the participants in the life sciences cluster. The event welcomed many international executives from large pharma as well as the financial community ... we are aware of a number of both partnering and investment discussions taking place and there will no doubt follow a number of announcements ... deals that were initiated or discussed at BioTrinity" David Mott, Investment Director, Oxford Capital Partners, 28th May 2008, following BioTrinity 2008


“Very rarely do we get access to as many potential customers and collaborators at one time. Already we are in discussions about future projects, the event helped us to continue to put OET on the map. OBN has certainly given us a springboard for continued development.” James Bernard, Chief Executive Officer, OET, 28th May 2008, following BioTrinity 2008


"The event attracted a good cross section of the industry, which provided us with excellent networking opportunities.", Paul Edwards, Chief Executive, Ruston Poole, April 2008, following BioTrinity 2008


"I found the feedback from presenting at the OBN BioTrinity meeting truly excellent. I not only had a lot of questions after the presentation but it generated press interest and many follow up meetings in the following days. This is testament to the quality of the attendees at the meeting." David Phipps, SVP, Sales and Marketing, BioFocus DPI (part of Galapagos), 23 April 2008


"A useful complement to the massive global partnering meetings, good presentations and networking but with a regional emphasis. A productive couple of days.", Phil Boyd, CFO, Syntaxin, April 2008, following BioTrinity 2008


"BioTrinity 2008 provided a great opportunity to renew existing contacts and make important new ones at a critical time as we expand our company's CRO business in the UK.", Mark Newall, Managing Director, TFS Trial Form Support, April 2008, following BioTrinity 2008


"BioTrinity 2008 was very useful to my company. It was a great opportunity to network and make new contacts." Anna Dunphy, Account Director (Investor Relations), De Facto Communications, April 2008, following BioTrinity 2008


"The Biotrinity Event was for us very useful, it offers a good change to meet possible partners and new business within 2 days. As a company from the Netherlands, we were able to meet and talk to at least 20 interesting delegates in these two days. Furthermore the introduction of our new breast scanner, the WeberGraphie, was made possible to a lot of potential business partners." Peter Faessen, Marketing and Sales Manager, Kleeven Medical BV, April 2008, following BioTrinity 2008


"We were delighted to exhibit at BioTrinity again this year. This gave us the opportunity to meet clients and potentail clients as well as meet new and existing professional contacts." Rob Evans, Business Development Director, FOCUS Insurance, April 2008, following BioTrinity 2008


"It was clear from Biotrinity 2008 that big Pharma want you to meet them personally to start negotiating deals, email and phone won't do. Biotrinity is one of the few forums that can bring everyone together to do this face to face." Janet Fernihough, Medical Projects Manager, Systems Biology Laboratory, April 2008, following BioTrinity 2008


"An extremely high-profile platform for both meeting existing stakeholders and networking new industry contacts, all under one roof." Ben Godfrey, Business Development Executive, LFI Molecular, April 2008, following BioTrinity 2008


"Excellent chance to get the latest news/views from opinion leaders Excellent networking opportunities Very well organised, enjoyable and great value" Peter Crocker, Director, AST Associates, April 2008, following BioTrinity 2008


"A great opportunity to catch up with what's going on and what's new in Oxfordshire and the South East." Lisa Mynheer, Director, DiagnOx, April 2008, following BioTrinity 2008


"A superbly organised event, slick, professional and thoroughly enjoyable" Matt Cawood, Head of Interim Management, SRG, April 2008, following BioTrinity 2008


"BioTrinity 2008 was a great success. It brought together the right mix of large, small and service provider companies with a very specific focus." Rod Cook, Partner, Biotech Personnel, April 2008, following BioTrinity 2008


"A well organised and valuable meeting with an excellent delegate mix and informative presentations." Geoff Dobson, Director, Coulter Partners, April 2008, following BioTrinity 2008


"An excellent meeting, high quality delegates and discussions." Dr. Riccardo Matjaz Bennett-Lovsey, Business Development Manager, Equinox Pharma, April 2008, following BioTrinity 2008


"I'm writing to congratulate you on a fantastic event yesterday. Your work with UKTI is much appreciated and from my talks with businesses at the event, you obviously show the same commitment and determination in support of them." Team Leader LifeSciences Sector Team, UKTI, April 2008, following BioTrinity 2008


"BioTrinity 2008 demonstrated the strength of the Oxfordshire Bioscience sector and its international importance." Ian Macpherson, Business Development Manager, The Oxford Science Park, April 2008, following BioTrinity 2008


"thank you for organising the conference which was a great success. There was a high calibre of participants and the event has raised the profile the Oxford and Thames Valley biotech cluster. This will create a rising tide for us all."
David Mott, Director, Oxford Capital Partners, 29th March 2007, following the inaugural BioTrinity conference.


"I would like to congratulate you on an excellent meeting."
Tim Haines, Partner, Abingworth Management, 29th March 2007, following the inaugural BioTrinity conference


"Congratulations on such a good event yesterday - I had a very productive day with lots of organized and impromptu meetings - a very worthwhile event for me".
Dr Charles Potter, CEO, Glide Pharma, 29th March 2007, following the inaugural BioTrinity conference.


"A fantastic event - being a sponsor was an excellent way of raising our profile...This was the busiest conference/exhibition we have attended in a long time, generating a large number of valuable high quality enquiries and contacts... you are to be congratulated on a well-organised and thoroughly successful event. We look forward to returning next year"
Dr Cheryl Scott, Bioscience Funding Adviser, Biotechnology Finance Advisory Service (BFAS), Finance South East Ltd 29th March 2007, following the inaugural BioTrinity conference.


"many thanks for organising a great meeting - it was highly informative, a great place to network, bounce "problems and ideas" off of other executives and get expert advice. Looking forward to next year's meeting."
Mohammad S Alavijeh, Co-founder and Managing Director, Pharmidex Pharmaceutical Services Ltd 29th March 2007, following the inaugural BioTrinity conference.


" it was an excellent day, well organised and presented, and what a wonderful turnout"
Rebecca Todd, Investment Associate, Oxford Capital Partners, 29th March 2007, following the inaugural BioTrinity conference


"A useful event well organised. The partnering worked well and the electronic partnering system was most excellent. I enjoyed the event and would come again next year."
Howard Tranter, Business Development Manager, Health Protection Agency, 30th March 2007 following the inaugural BioTrinity conference


"it was a brilliant event...I met all sorts of useful contacts in many different spheres, I learnt a lot on various topics through talks, workshops and networking"
Helen Irving, Business Manager, Oxford Expression Technologies, 29th March 2007, following the inaugural BioTrinity conference.


"Kudos to the OBN team for organising the Biotrinity 2007...the fantastic response was quite evident."
Ashish Kumar, Bioinformatics and Statistical analysis, Cardio Medicine, University of Oxford, Wellcome Trust Centre for Human Genetics, 29th March 2007,following the inaugural BioTrinity conference.


"I thought that BioTrinity 2007 was extremely good. The partnering side worked particularly well and the atmosphere was very sociable and relaxed. Congratulations to you and your team!"
Karen Bohling, Marketing Advisor to Boult Wade Tennant, 29th March 2007, following the inaugural BioTrinity conference.


"Thank you for organising an excellent event. The Stimutran companies were delighted!"
Valerie Pondaven, International Project Executive, EIC Kent Business Link, 29th March 2007, following the inaugural BioTrinity conference."


"An excellent event......The success of the presentations, workshops and partnering was great.... Looking forward to next year!!"
Ian Macpherson, Business Development Manager, The Oxford Science Park, 29th March 2007, following the inaugural BioTrinity conference


"congratulations for pulling off an excellent event - VERY well done indeed - the venue won't be big enough for next year!"
Lisa Mynheer, Project Manager, DiagnOx Incubator 29th March 2007, following the inaugural BioTrinity conference


"the event was professionally managed, interesting and achieved its primary goal, to establish an event to complement ERBI and Genesis....Lots of valuable contacts all together on one day"
Valerie Tate, Chief Executive, BioValue, 29th March 2007 following the inaugural BioTrinity conference


"Congratulations to you and your hardworking team in the planning and organisation of an excellent inaugural event. We, along with our co-sponsors Chubb thought it was an excellent two days...we hope it will be a regular feature of the Bio calendar...and we will be very happy to be involved again."
Rob Evans, Business Development Director, Focus Insurance Services, 29th March 2007, following the inaugural BioTrinity conference."


Take the time to register for BioTrinity register for BioTrinity 2009.





BioTrinity 2014 highlights
1,014 delegates from 32 countries
624 companies
184 speakers
107 company showcase presentations
2,462 one-to-one meetings
130+ investor delegates from 12 countries
61 exhibitors
80 global pharma/corporate venture delegates
33 global pharma/medical technology corporates